Julie Rathbun | Investor Relations |
Mark Litton | President & Chief Executive Officer |
Hans Moebius | Chief Medical Officer |
Andrew Tsai | Jefferies |
Paul Matteis | Stifel |
Corinne Jenkins | Goldman Sachs |
Jason Butler | JMP |
00:05 Welcome to Athira Pharma’s Conference Call to discuss its Full-Year 2021 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Following the conclusion of the prepared remarks, we will conduct a question-and-answer session and instructions will follow at that time. This conference call is being recorded today, March 24, 2022. 00:28 I would like to turn the conference call over to Julie Rathbun, Head of Investor and Public Relations at Athira Pharma.